MedTrace Logo

Sphenopalatine Ganglion Blocks RCT

NCT03666663 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-10-11

Study results available
· View outcomes & findings →

Summary

RCT of Sphenopalatine Ganglion (SPG) Blocks using anesthetics vs. placebo for migraine.

Conditions

Interventions

DRUG

Lidocaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Bupivacaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Ropivacaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Placebo

Placebo Saline using the Sphenocath device- cleared by FDA

Sponsors & Collaborators

Principal Investigators

  • Nina Riggins, MD · UCSF Headache Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2021-07-08
Completion
2021-07-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666663 on ClinicalTrials.gov